Industry spurs challenge to US drugs regulator
The European Commission's move to approve new medicines faster than in the US is a clear challenge to the supremacy of the US Food and Drug Administration. The FDA has set the standard for approving
The European Commission's move to approve new medicines faster than in the US is a clear challenge to the supremacy of the US Food and Drug Administration. The FDA has set the standard for approving